Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 deoxyribonucleic acid plasmid encoding spike protein (procedure)
SCTID: 1193583000, Defined, Active
1193583000|Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 deoxyribonucleic acid plasmid encoding spike protein (procedure)|
- en 2019-ncov dna plasmid encoding spike protein immunisation
- en 2019-ncov dna plasmid encoding spike protein immunization
- en 2019-ncov dna plasmid encoding spike protein vaccination
- en 2019 novel coronavirus dna plasmid encoding spike protein immunisation
- en 2019 novel coronavirus dna plasmid encoding spike protein immunization
- en 2019 novel coronavirus dna plasmid encoding spike protein vaccination
- en Administration of sars-cov-2 dna plasmid encoding spike protein vaccine
- en Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 deoxyribonucleic acid plasmid encoding spike protein
- en Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 deoxyribonucleic acid plasmid encoding spike protein (procedure)
- en Covid-19 dna plasmid encoding spike protein immunisation
- en Covid-19 dna plasmid encoding spike protein immunization
- en Covid-19 dna plasmid encoding spike protein vaccination
- en Sars-cov-2 dna plasmid encoding spike protein immunisation
- en Sars-cov-2 dna plasmid encoding spike protein immunization
- en Sars-cov-2 dna plasmid encoding spike protein vaccination
- en Severe acute respiratory syndrome coronavirus 2 dna plasmid encoding spike protein vaccination